MoonLake Immunotherapeutics (MLTX)
NASDAQ·Healthcare·Biotechnology
$16.77
-0.47%
Mkt Cap $1.21B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | — | — | — | -$0.92 | -$0.92 | +0.00% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.89 | -$1.10 | -23.60% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$0.73 | -$0.87 | -19.18% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.76 | -$0.63 | +17.11% | — | — |
| Q1 2025 Feb 26, 2025 | — | $101.85K | — | -$0.53 | -$0.72 | -35.85% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.44 | -$0.56 | -27.27% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.28 | -$0.39 | -39.29% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.21 | -$0.22 | -4.76% | — | — |
| Q1 2024 Feb 29, 2024 | — | $19.74K | — | -$0.21 | -$0.12 | +42.86% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.22 | -$0.18 | +18.18% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.25 | -$0.23 | +8.00% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$0.28 | -$0.23 | +17.86% | — | — |
| Q1 2023 Mar 20, 2023 | — | — | — | -$0.32 | -$0.31 | +3.13% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.32 | -$0.27 | +15.62% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.54 | -$0.34 | +37.04% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$0.43 | — | — | — |
| Q1 2022 Feb 17, 2022 | — | — | — | — | -$0.15 | — | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | — | -$0.17 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.89 | — | — | — |
| Q2 2021 May 21, 2021 | — | — | — | — | -$0.01 | — | — | — |